TrialHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2026

Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial.

Elisa Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.